The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Open accessAbstract
BACKGROUND: In 2002, we reported the initial results of a trial comparing radical prostatectomy with watchful waiting in the management of early prostate cancer. After three more years of follow-up, we report estimated 10-year results. METHODS: From October 1989 through February 1999, 695 men with early prostate cancer (mean age, 64.7 years) were randomly assigned to radical prostatectomy (347 men) or watchful waiting (348 men). The follow-up was complete through 2003, with blinded evaluation of the causes of death. The primary end point was death due to prostate cancer; the secondary end points were death from any cause, metastasis, and local progression. RESULTS: During a median of 8.2 years of follow-up, 83 men in the surgery group and 106 men in the watchful-waiting group died (P=0.04). In 30 of the 347 men assigned to surgery (8.6 percent) and 50 of the 348 men assigned to watchful waiting (14.4 percent), death was due to prostate cancer. The difference in the cumulative incidence of death due to prostate cancer increased from 2.0 percentage points after 5 years to 5.3 percentage points after 10 years, for a relative risk of 0.56 (95 percent confidence interval, 0.36 to 0.88; P=0.01 by Gray's test). For distant metastasis, the corresponding increase was from 1.7 to 10.2 percentage points, for a relative risk in the surgery group of 0.60 (95 percent confidence interval, 0.42 to 0.86; P=0.004 by Gray's test), and for local progression, the increase was from 19.1 to 25.1 percentage points, for a relative risk of 0.33 (95 percent confidence interval, 0.25 to 0.44; P<0.001 by Gray's test). CONCLUSIONS: Radical prostatectomy reduces disease-specific mortality, overall mortality, and the risks of metastasis and local progression. The absolute reduction in the risk of death after 10 years is small, but the reductions in the risks of metastasis and local tumor progression are substantial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One of the “gold standard” treatments for early stage prostate cancer is radical prostatectomy (RP), which has established long-term benefit (2-5).”
From Men's experience with penile rehabilitation following radical prostatectomy: a qualitative study with the goal of informing a therapeutic intervention. (2015) · cites this paper as [2]
Citations
Cites
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Results of Conservative Management of Clinically Localized Prostate Cancer
Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J.-E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M., & Warner, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300403 · Cited by 928
Self-citationA Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
Holmberg, L., Bill-Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Häggman, M., Andersson, S.-O., Spångberg, A., Busch, C., Nordling, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012794 · Cited by 817
Self-citationQuality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J.-E., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 722
Self-citationNatural History of Early, Localized Prostate Cancer
Johansson, J.-E. (2004) · JAMA · doi:10.1001/jama.291.22.2713 · Cited by 703
Self-citationPotosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680
The role of radical prostatectomy in the management of prostatic cancer
Walsh, P. C., & Lepor, H. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+<526::aid-cncr2820601515>3.0.co;2-9 · Cited by 131
Carcinoma of the prostate. Hormonal therapy
Grayhack, J. T., Keeler, T. C., & Kozlowski, J. M. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+<589::aid-cncr2820601526>3.0.co;2-r · Cited by 111
Staging Pelvic Lymphadenectomy for Carcinoma of the Prostate: Risk Versus Benefit
Brendler, C. B., Cleeve, L. K., Anderson, E. E., & Paulson, D. F. (1980) · The Journal of Urology · doi:10.1016/s0022-5347(17)55696-7 · Cited by 106
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden
Johansson, J.-E. (1997) · JAMA · doi:10.1001/jama.277.6.467 · Cited by 102
Self-citation
Research works printed but not linked: 1
- 10.1002/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO;2-T · doi:10.1002/1097-0142(19930715)72:2<310::aid-cncr2820720203>3.0.co;2-t
Cited by
EAU Guidelines on Prostate Cancer
Heidenreich, A., Aus, G., Bolla, M., Joniau, S., Matveev, V. B., Schmid, H. P., & Zattoni, F. (2008) · European Urology · doi:10.1016/j.eururo.2007.09.002 · Cited by 3,136
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810696 · Cited by 2,906
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Garmo, H., Stark, J. R., Busch, C., Nordling, S., Häggman, M., Andersson, S.-O., Bratell, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011967 · Cited by 1,900
Self-citationFuture of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
Smith, B. D., Smith, G. L., Hurria, A., Hortobagyi, G. N., & Buchholz, T. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8983 · Cited by 1,721
Heidenreich, A., Bellmunt, J., Bolla, M., Joniau, S., Mason, M., Matveev, V., Mottet, N., Schmid, H.-P., van der Kwast, T., Wiegel, T., et al. (2011) · European Urology · doi:10.1016/j.eururo.2010.10.039 · Cited by 1,492
Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1- 13 C]Pyruvate
Nelson, S. J., Kurhanewicz, J., Vigneron, D. B., Larson, P. E. Z., Harzstark, A. L., Ferrone, M., van Criekinge, M., Chang, J. W., Bok, R., Park, I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006070 · Cited by 1,286
Thompson, I. M., Tangen, C. M., Paradelo, J., Lucia, M. S., Miller, G., Troyer, D., Messing, E., Forman, J., Chin, J., Swanson, G., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2008.11.032 · Cited by 1,227
Ilic, D., Neuberger, M. M., Djulbegovic, M., & Dahm, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004720.pub3 · Cited by 1,150
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
Thompson, I., Thrasher, J. B., Aus, G., Burnett, A. L., Canby-Hagino, E. D., Cookson, M. S., D’Amico, A. V., Dmochowski, R. R., Eton, D. T., Forman, J. D., et al. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.03.003 · Cited by 1,113
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
Lilja, H., Ulmert, D., & Vickers, A. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2351 · Cited by 921
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
Demichelis, F., Fall, K., Perner, S., Andrén, O., Schmidt, F., Setlur, S. R., Hoshida, Y., Mosquera, J.-M., Pawitan, Y., Lee, C., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210237 · Cited by 645
Self-citationBill-Axelson, A., Holmberg, L., Filen, F., Ruutu, M., Garmo, H., Busch, C., Nordling, S., Haggman, M., Andersson, S.-O., Bratell, S., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn255 · Cited by 603
Self-citationWilt, T. J., MacDonald, R., Rutks, I., Shamliyan, T. A., Taylor, B. C., & Kane, R. L. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-6-200803180-00209 · Cited by 597
Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou, R., Croswell, J. M., Dana, T., Bougatsos, C., Blazina, I., Fu, R., Gleitsmann, K., Koenig, H. C., Lam, C., Maltz, A., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-11-201112060-00375 · Cited by 573
Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975
La Vecchia, C., Bosetti, C., Lucchini, F., Bertuccio, P., Negri, E., Boyle, P., & Levi, F. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp530 · Cited by 559
Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality
Tsai, H. K., D'Amico, A. V., Sadetsky, N., Chen, M.-H., & Carroll, P. R. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm168 · Cited by 520
Prostate Specific Antigen Best Practice Statement: 2009 Update
Greene, K. L., Albertsen, P. C., Babaian, R. J., Carter, H. B., Gann, P. H., Han, M., Kuban, D. A., Sartor, A. O., Stanford, J. L., Zietman, A., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.07.093 · Cited by 517
Interpreting trends in cancer patient survival
DICKMAN, P. W., & ADAMI, H. ‐. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01677.x · Cited by 508
Self-citationScreening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00008 · Cited by 505
D'Amico, A. V., Denham, J. W., Crook, J., Chen, M.-H., Goldhaber, S. Z., Lamb, D. S., Joseph, D., Tai, K.-H., Malone, S., Ludgate, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.3369 · Cited by 501
Radical Prostatectomy or Watchful Waiting in Prostate Cancer — 29-Year Follow-up
Bill-Axelson, A., Holmberg, L., Garmo, H., Taari, K., Busch, C., Nordling, S., Häggman, M., Andersson, S.-O., Andrén, O., Steineck, G., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1807801 · Cited by 495
Self-citationProstate-specific membrane antigen expression as a predictor of prostate cancer progression
Perner, S., Hofer, M. D., Kim, R., Shah, R. B., Li, H., Möller, P., Hautmann, R. E., Gschwend, J. E., Kuefer, R., & Rubin, M. A. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.11.012 · Cited by 455
Contemporary Trends in Low Risk Prostate Cancer: Risk Assessment and Treatment
Cooperberg, M. R., Broering, J. M., Kantoff, P. W., & Carroll, P. R. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.03.135 · Cited by 442
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
Attard, G., Clark, J., Ambroisine, L., Fisher, G., Kovacs, G., Flohr, P., Berney, D., Foster, C. S., Fletcher, A., Gerald, W. L., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1210640 · Cited by 438
Stephenson, A. J., Kattan, M. W., Eastham, J. A., Bianco, F. J., Yossepowitch, O., Vickers, A. J., Klein, E. A., Wood, D. P., & Scardino, P. T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2501 · Cited by 419
Damber, J.-E., & Aus, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60729-1 · Cited by 418
Quantifying the role of PSA screening in the US prostate cancer mortality decline
Etzioni, R., Tsodikov, A., Mariotto, A., Szabo, A., Falcon, S., Wegelin, J., diTommaso, D., Karnofski, K., Gulati, R., Penson, D. F., et al. (2008) · Cancer Causes & Control · doi:10.1007/s10552-007-9083-8 · Cited by 423
Turkbey, B., Shah, V. P., Pang, Y., Bernardo, M., Xu, S., Kruecker, J., Locklin, J., Baccala, A. A., Rastinehad, A. R., Merino, M. J., et al. (2011) · Radiology · doi:10.1148/radiol.10100667 · Cited by 389
Biosensors: the new wave in cancer diagnosis
Mousa, S. (2010) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s13465 · Cited by 381
Denham, J. W., Steigler, A., Lamb, D. S., Joseph, D., Mameghan, H., Turner, S., Matthews, J., Franklin, I., Atkinson, C., North, J., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70348-x · Cited by 375
Active Surveillance for Prostate Cancer: For Whom?
Klotz, L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3134 · Cited by 353
Walsh, P. C., DeWeese, T. L., & Eisenberger, M. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp0706784 · Cited by 321
The Changing Face of Prostate Cancer
Cooperberg, M. R., Moul, J. W., & Carroll, P. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.9751 · Cited by 318
Zelefsky, M. J., Eastham, J. A., Cronin, A. M., Fuks, Z., Zhang, Z., Yamada, Y., Vickers, A., & Scardino, P. T. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.2265 · Cited by 310
Lin, K., Lipsitz, R., Miller, T., & Janakiraman, S. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00009 · Cited by 310
Is it time to consider a role for MRI before prostate biopsy?
Ahmed, H. U., Kirkham, A., Arya, M., Illing, R., Freeman, A., Allen, C., & Emberton, M. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.18 · Cited by 309
Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Wong, Y.-N., Mitra, N., Hudes, G., Localio, R., Schwartz, J. S., Wan, F., Montagnet, C., & Armstrong, K. (2006) · JAMA · doi:10.1001/jama.296.22.2683 · Cited by 305
Mehra, R., Tomlins, S. A., Shen, R., Nadeem, O., Wang, L., Wei, J. T., Pienta, K. J., Ghosh, D., Rubin, M. A., Chinnaiyan, A. M., et al. (2007) · Modern Pathology · doi:10.1038/modpathol.3800769 · Cited by 303
Berglund, R. K., Masterson, T. A., Vora, K. C., Eggener, S. E., Eastham, J. A., & Guillonneau, B. D. (2008) · Journal of Urology · doi:10.1016/j.juro.2008.07.051 · Cited by 281
Coelho, R. F., Rocco, B., Patel, M. B., Orvieto, M. A., Chauhan, S., Ficarra, V., Melegari, S., Palmer, K. J., & Patel, V. R. (2010) · Journal of Endourology · doi:10.1089/end.2010.0295 · Cited by 280
Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological study
Collin, S. M., Martin, R. M., Metcalfe, C., Gunnell, D., Albertsen, P. C., Neal, D., Hamdy, F., Stephens, P., Lane, J. A., Moore, R., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70104-9 · Cited by 272
YouTube as Source of Prostate Cancer Information
Steinberg, P. L., Wason, S., Stern, J. M., Deters, L., Kowal, B., & Seigne, J. (2010) · Urology · doi:10.1016/j.urology.2008.07.059 · Cited by 271
Kelloff, G. J., Lippman, S. M., Dannenberg, A. J., Sigman, C. C., Pearce, H. L., Reid, B. J., Szabo, E., Jordan, V. C., Spitz, M. R., Mills, G. B., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1104 · Cited by 270
Contemporary Risk Profile of Prostate Cancer in the United States
Shao, Y.-H., Demissie, K., Shih, W., Mehta, A. R., Stein, M. N., Roberts, C. B., DiPaola, R. S., & Lu-Yao, G. L. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp262 · Cited by 269
Nam, R. K., Sugar, L., Yang, W., Srivastava, S., Klotz, L. H., Yang, L.-Y., Stanimirovic, A., Encioiu, E., Neill, M., Loblaw, D. A., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604054 · Cited by 257
TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
Gopalan, A., Leversha, M. A., Satagopan, J. M., Zhou, Q., Al-Ahmadie, H. A., Fine, S. W., Eastham, J. A., Scardino, P. T., Scher, H. I., Tickoo, S. K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2467 · Cited by 246
deSouza, N. M., Riches, S. F., VanAs, N. J., Morgan, V. A., Ashley, S. A., Fisher, C., Payne, G. S., & Parker, C. (2008) · Clinical Radiology · doi:10.1016/j.crad.2008.02.001 · Cited by 241
Erectile Function Recovery Rate after Radical Prostatectomy: A Meta-Analysis
Tal, R., Alphs, H. H., Krebs, P., Nelson, C. J., & Mulhall, J. P. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01351.x · Cited by 235
Incidence of Initial Local Therapy Among Men With Lower-Risk Prostate Cancer in the United States
Miller, D. C., Gruber, S. B., Hollenbeck, B. K., Montie, J. E., & Wei, J. T. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj308 · Cited by 227
Positive Surgical Margins at Radical Prostatectomy Predict Prostate Cancer Specific Mortality
Wright, J. L., Dalkin, B. L., True, L. D., Ellis, W. J., Stanford, J. L., Lange, P. H., & Lin, D. W. (2010) · Journal of Urology · doi:10.1016/j.juro.2010.02.017 · Cited by 223
Delayed Versus Immediate Surgical Intervention and Prostate Cancer Outcome
Warlick, C., Trock, B. J., Landis, P., Epstein, J. I., & Carter, H. B. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj072 · Cited by 219
Molecular sampling of prostate cancer: a dilemma for predicting disease progression
Sboner, A., Demichelis, F., Calza, S., Pawitan, Y., Setlur, S. R., Hoshida, Y., Perner, S., Adami, H.-O., Fall, K., Mucci, L. A., et al. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-8 · Cited by 218
Self-citationvan As, N. J., Norman, A. R., Thomas, K., Khoo, V. S., Thompson, A., Huddart, R. A., Horwich, A., Dearnaley, D. P., & Parker, C. C. (2008) · European Urology · doi:10.1016/j.eururo.2008.02.039 · Cited by 216
Focal Cryosurgery: Encouraging Health Outcomes for Unifocal Prostate Cancer
Lambert, E. H., Bolte, K., Masson, P., & Katz, A. E. (2007) · Urology · doi:10.1016/j.urology.2007.02.047 · Cited by 205
Alibhai, S. M. H., Leach, M., Tomlinson, G., Krahn, M. D., Fleshner, N., Holowaty, E., & Naglie, G. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji313 · Cited by 204
Catalona, W. J. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.11.001 · Cited by 197
The role of anxiety in prostate carcinoma: A structured review of the literature
Dale, W., Bilir, P., Han, M., & Meltzer, D. (2005) · Cancer · doi:10.1002/cncr.21198 · Cited by 201
Interpreting Trends in Prostate Cancer Incidence and Mortality in the Five Nordic Countries
Kvale, R., Auvinen, A., Adami, H.-O., Klint, A., Hernes, E., Moller, B., Pukkala, E., Storm, H. H., Tryggvadottir, L., Tretli, S., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm249 · Cited by 195
Self-citationMenon, M., Bhandari, M., Gupta, N., Lane, Z., Peabody, J. O., Rogers, C. G., Sammon, J., Siddiqui, S. A., & Diaz, M. (2010) · European Urology · doi:10.1016/j.eururo.2010.09.010 · Cited by 194
Kularatne, S. A., Wang, K., Santhapuram, H.-K. R., & Low, P. S. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900069d · Cited by 191
MULLERAD, M., HRICAK, H., KUROIWA, K., PUCAR, D., CHEN, H.-N., KATTAN, M. W., & SCARDINO, P. T. (2005) · Journal of Urology · doi:10.1097/01.ju.0000181224.95276.82 · Cited by 193
Who Ordered That? The Economics of Treatment Choices in Medical Care
Chandra, A., Cutler, D., & Song, Z. (2011) · Handbook of health economics · doi:10.1016/b978-0-444-53592-4.00006-2 · Cited by 196
Trends in Mortality From Urologic Cancers in Europe, 1970–2008
Bosetti, C., Bertuccio, P., Chatenoud, L., Negri, E., La Vecchia, C., & Levi, F. (2011) · European Urology · doi:10.1016/j.eururo.2011.03.047 · Cited by 187
Loeb, S., Roehl, K. A., Antenor, J. A. V., Catalona, W. J., Suarez, B. K., & Nadler, R. B. (2006) · Urology · doi:10.1016/j.urology.2005.08.040 · Cited by 184
The role of Src in prostate cancer
Fizazi, K. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm086 · Cited by 183
Coelho, R. F., Palmer, K. J., Rocco, B., Moniz, R. R., Chauhan, S., Orvieto, M. A., Coughlin, G., & Patel, V. R. (2010) · European Urology · doi:10.1016/j.eururo.2010.02.001 · Cited by 178
Screening for prostate cancer: an updated Cochrane systematic review
Ilic, D., O’Connor, D., Green, S., & Wilt, T. J. (2011) · BJU International · doi:10.1111/j.1464-410x.2010.10032.x · Cited by 176
Genome-wide association study identifies new prostate cancer susceptibility loci
Schumacher, F. R., Berndt, S. I., Siddiq, A., Jacobs, K. B., Wang, Z., Lindstrom, S., Stevens, V. L., Chen, C., Mondul, A. M., Travis, R. C., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr295 · Cited by 171
Overdiagnosis and overtreatment of early detected prostate cancer
Bangma, C. H., Roemeling, S., & Schröder, F. H. (2007) · World Journal of Urology · doi:10.1007/s00345-007-0145-z · Cited by 169
van As, N. J., de Souza, N. M., Riches, S. F., Morgan, V. A., Sohaib, S. A., Dearnaley, D. P., & Parker, C. C. (2009) · European Urology · doi:10.1016/j.eururo.2008.11.051 · Cited by 169
Andrén, O., Fall, K., Franzén, L., Andersson, S.-O., Johansson, J.-E., & Rubin, M. A. (2006) · Journal of Urology · doi:10.1016/s0022-5347(05)00734-2 · Cited by 166
Self-citationWill focal therapy become a standard of care for men with localized prostate cancer?
Ahmed, H. U., Pendse, D., Illing, R., Allen, C., van der Meulen, J. H., & Emberton, M. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0959 · Cited by 163
Physician Visits Prior to Treatment for Clinically Localized Prostate Cancer
Jang, T. L. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.1 · Cited by 163
Rapid progression of prostate cancer in men with a BRCA2 mutation
the Hereditary Breast Cancer Study Group, Narod, S. A., Neuhausen, S., Vichodez, G., Armel, S., Lynch, H. T., Ghadirian, P., Cummings, S., Olopade, O., Stoppa-Lyonnet, D., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604453 · Cited by 162
Roemeling, S., Roobol, M. J., de Vries, S. H., Wolters, T., Gosselaar, C., van Leenders, G. J. L. H., & Schröder, F. H. (2007) · European Urology · doi:10.1016/j.eururo.2006.11.053 · Cited by 160
Ali, K., Gunnar, A., Jan‐Erik, D., Lilja, H. G., Pär, L., & Jonas, H. (2006) · International Journal of Cancer · doi:10.1002/ijc.22161 · Cited by 157
Perioperative Activation of Disseminated Tumor Cells in Bone Marrow of Patients With Prostate Cancer
Weckermann, D., Polzer, B. M., Ragg, T., Blana, A., Schlimok, G., Arnholdt, H., Bertz, S., Harzmann, R., & Klein, C. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0563 · Cited by 157
Whole Gland Primary Prostate Cryoablation: Initial Results From the Cryo On-Line Data Registry
Jones, J. S., Rewcastle, J. C., Donnelly, B. J., Lugnani, F. M., Pisters, L. L., & Katz, A. E. (2008) · Journal of Urology · doi:10.1016/j.juro.2008.04.027 · Cited by 158
Donnelly, B. J., Saliken, J. C., Brasher, P. M. A., Ernst, S. D., Rewcastle, J. C., Lau, H., Robinson, J., & Trpkov, K. (2010) · Cancer · doi:10.1002/cncr.24779 · Cited by 158
Nomograms for staging, prognosis, and predicting treatment outcomes
Touijer, K. A., & Scardino, P. T. (2009) · Cancer · doi:10.1002/cncr.24352 · Cited by 155
Prostate-specific antigen in the early detection of prostate cancer
Thompson, I. M., & Ankerst, D. P. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060955 · Cited by 155
Mozer, P., Morgan Rouprêt, A., Cossec, C. L., Granger, B., Compérat, É., Górski, A. D., Cussenot, O., & Renard‐Penna, R. (2014) · British Journal of Urology · doi:10.1111/bju.12690 · Cited by 151
Overtreatment of men with low‐risk prostate cancer and significant comorbidity
Daskivich, T. J., Chamie, K., Kwan, L. C., Labo, J., Palvolgyi, R., Dash, A., Greenfield, S., & Litwin, M. S. (2010) · Cancer · doi:10.1002/cncr.25751 · Cited by 160
Denberg, T. D., Melhado, T. V., & Steiner, J. F. (2006) · Cancer · doi:10.1002/cncr.22033 · Cited by 154
Guía de la EAU para el Cáncer de Próstata
Heidenreich, A., Aus, G., Bolla, M., Joniau, S., Matveev, V. B., Schmid, H. P., Zattoni, F., & European Association of Urology (2009) · Hispana · Cited by 149
Can nomograms be superior to other prediction tools?
Shariat, S. F., Umberto Capitanio, A., Claudio Jeldres, A., & Karakiewicz, P. I. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.08073.x · Cited by 150
Hadley, J., Yabroff, K. R., Barrett, M. J., Penson, D. F., Saigal, C. S., & Potosky, A. L. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq393 · Cited by 155
The evolving biology and treatment of prostate cancer
Taichman, R. S., Loberg, R. D., Mehra, R., & Pienta, K. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31791 · Cited by 146
Evans, S., Metcalfe, C. D., Ibrahim, F., Persad, R. A., & Ben‐Shlomo, Y. (2008) · International Journal of Cancer · doi:10.1002/ijc.23500 · Cited by 145
Decision aids for localized prostate cancer treatment choice: Systematic review and meta‐analysis
Violette, P. D., Agoritsas, T., Alexander, P. E., Riikonen, J. M., Santti, H., Agarwal, A., Bhatnagar, N., Dahm, P., Montori, V. M., Guyatt, G. H., et al. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21272 · Cited by 148
Parker, C. C., Muston, D., Melia, J., Moss, S., & Dearnaley, D. P. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603105 · Cited by 142
Giovanni Lughezzani, A., Briganti, A., Karakiewicz, P. I., Kattan, M. W., Montorsi, F., Shariat, S. F., & Vickers, A. J. (2010) · European Urology · doi:10.1016/j.eururo.2010.07.034 · Cited by 148
A Common 8q24 Variant in Prostate and Breast Cancer from a Large Nested Case-Control Study
Schumacher, F. R., Feigelson, H. S., Cox, D. G., Haiman, C. A., Albanes, D., Buring, J. E., Calle, E. E., Chanock, S. J., Colditz, G. A., Diver, W. R., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3591 · Cited by 142
Barocas, D. A., Salem, S. M., Kordan, Y., Herrell, S. D., Chang, S. S., Clark, P. E., Davis, R., Baumgartner, R. G., Phillips, S. E., Cookson, M. S., et al. (2010) · The Journal of Urology · doi:10.1016/j.juro.2009.11.017 · Cited by 142
Vis, A. N., Schröder, F. H., & van der Kwast, T. (2006) · European Urology · doi:10.1016/j.eururo.2005.11.030 · Cited by 141
Cooperberg, M. R., Freedland, S. J., Pasta, D. J., Elkin, E. P., Presti, J. C., Amling, C. L., Terris, M. K., Aronson, W. J., Kane, C. J., & Carroll, P. R. (2006) · Cancer · doi:10.1002/cncr.22262 · Cited by 140
Granlund, K. L., Tee, S.-S., Vargas, H. A., Lyashchenko, S. K., Reznik, E., Fine, S., Laudone, V., Eastham, J. A., Touijer, K. A., Reuter, V. E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.024 · Cited by 138
Predictors of patient preferences and treatment choices for localized prostate cancer
Sommers, B. D., Beard, C. J., D'Amico, A. V., Kaplan, I. D., Richie, J. P., & Zeckhauser, R. (2008) · Cancer · doi:10.1002/cncr.23807 · Cited by 137
Hurtes, X., Morgan Rouprêt, A., Vaessen, C., Pereira, H., d’Arcier, B. F., Cormier, L., & Bruyère, F. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10849.x · Cited by 135
Barocas, D. A., Cowan, J. E., Smith, J. A. J., Carroll, P. R., & CaPSURE Investigators (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.06.019 · Cited by 134
Metadata
- Authors
- Bill-Axelson, A., Holmberg, L., Ruutu, M., Häggman, M., Andersson, S.-O., Bratell, S., Spångberg, A., Busch, C., Nordling, S., Garmo, H., Palmgren, J., Adami, H.-O., Norlén, B. J., & Johansson, J.-E.
- Affiliations
- University of Helsinki (FI)
- Linköping University Hospital (SE)
- Uppsala University Hospital (SE)
- Karolinska Institutet (SE)
- Harvard University (US)
- Örebro University Hospital (SE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-05-12
- Volume
- 352
- Issue
- 19
- Pages
- 1977-1984
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4233182856
- Cited by
- 1,111
- References
- 11
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 18 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 23 · 2018: 21 · 2017: 20 · 2016: 24 · 2015: 35 · 2014: 35 · 2013: 50 · 2012: 68
- FWCI
- 120.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- radical prostatectomy, expectant management, early-stage prostate cancer, prostate cancer mortality, distant metastasis, local tumor progression, all-cause mortality, long-term follow-up, surgical versus conservative treatment
- MeSH terms
- Aged, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Metastasis, Prostatectomy, Prostatic Neoplasms, Incidence, Proportional Hazards Models, Survival Analysis, Disease Progression, Antineoplastic Agents, Hormonal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.